Position in ALVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$57,848,473
New position
Shares Held
15,677,093
first reported quarter
Ownership
4.39%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#1
of 72 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rubric Capital Management LP holds $1,630,260,569 across 8 Drug Manufacturers - Specialty & Generic names. ALVO ranks #5 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
34,168,743 | $542,599,638 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
15,575,000 | $527,681,000 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
3,999,800 | $255,787,210 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
10,168,660 | $176,019,504 | |
| 5 | ALVO |
Alvotech
This page
|
15,677,093 | $57,848,473 | |
| 6 | COLL |
Collegium Pharmaceutical, Inc
|
1,279,611 | $46,321,918 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
258,131 | $21,368,084 | |
| 8 | TXMD |
TherapeuticsMD, Inc.
|
1,192,191 | $2,634,742 |
All Filings in ALVO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,848,473 | 15,677,093 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||